Filter Results:
(988)
Show Results For
- All HBS Web
(988)
- People (4)
- News (257)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (395)
Show Results For
- All HBS Web
(988)
- People (4)
- News (257)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (395)
- 29 Jan 2021
- Op-Ed
How Influencers, Celebrities, and FOMO Can Win Over Vaccine Skeptics
of the much harsher consequences. India’s fight against HIV provides a good example to follow: Cipla, the maker of generic drugs, provided a simple message: Its low-priced drugs treated life-threatening conditions, and this message was... View Details
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 07 Jan 2002
- Research & Ideas
How Marketing Can Reduce Worldwide Poverty
on-the-ground advocacy—to go get a free eye exam or a blood pressure check-up. Easy. Your basic principles of sales and promotion will carry the day. If your charge is minimizing smoking or drug use, well, your job becomes rather more... View Details
Keywords: by Martha Lagace
- 01 Jun 2004
- News
Working the Street
Monte (“End of the Santa Fe Trail”) remains a magnet for prostitutes, particularly transvestites. Police dub them “heeshees” (he/shes); some dress in spiky heels and miniskirts, sporting silicone implants (done in Mexico) that a Hollywood starlet would covet.... View Details
- 2023
- Article
Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance
By: Alexander O. Everhart, Soumya Sen, Ariel D. Stern, Yi Zhu and Pinar Karaca-Mandic
Importance: Most regulated medical devices enter the U.S. market via the 510(k) regulatory submission pathway, wherein manufacturers demonstrate that applicant devices are “substantially equivalent” to 1 or more “predicate” devices (legally marketed medical devices... View Details
Everhart, Alexander O., Soumya Sen, Ariel D. Stern, Yi Zhu, and Pinar Karaca-Mandic. "Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance." JAMA, the Journal of the American Medical Association 329, no. 2 (2023): 144–156.
- Web
Charts & Statistics - Leadership
Oklahoma City bombing Influence: Medium-Low 1900 s 19 First significant enforcement of Sherman Antitrust Act Pure Food and Drug Act; breakup of beef trust Excise Tax imposed on corporations Tariff Act forces corporations to open their... View Details
- Web
Industry Information - Alumni
biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provide local expertise along with a global perspective. BioSpace Leading online community for industry news and... View Details
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
for a new ulcer drug and discover one in a surprising way, that's not quite as amazing as if you are looking for a new ulcer drug and discover instead a new artificial sweetener (this is how Aspartame,... View Details
Keywords: by Sarah Jane Gilbert
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 12 Oct 2017
- News
Fighting Poverty One Neighborhood at a Time
in the mid-1990s had one of the highest crime rates in the country, a significant drug problem, and a failing school. Local real estate developer and philanthropist Tom Cousins, who became the founder of Purpose Built Communities, led the... View Details
Keywords: Deborah Blagg
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the 1990s, the U.S. and European... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
- 01 Dec 2013
- News
Your Own Medicine
drug he has ever taken that directly targets his DMD, a rare degenerative disorder in boys that weakens the body's muscles, usually putting sufferers in wheelchairs in adolescence and shutting down their heart and lungs in their 20s. For... View Details
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high... View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several... View Details
Keywords: by Manda Salls
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every... View Details
Keywords: Julia Hanna
Jack M. Eckerd
Eckerd introduced the self-service retailing model in his drug store operations and, in the process, built the largest drug store retail chain in the South. Eckerd was one of the firsts to recognize the... View Details
Keywords: Retail
John W. Culligan
Culligan capped off a 49-year career with American Home Products as its CEO from 1981 to 1986. During his tenure he doubled AHP’s research & development budget, building a pipeline of 24 new drugs and 48 new View Details
Keywords: Healthcare
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
drug business. They relied, however, on licensing rather than building their own in-house capabilities for drug discovery and commercialization. In the low-tech OTC [over-the-counter] sector, they... View Details